Investor Presentation - Winter/Spring 2024 slide image

Investor Presentation - Winter/Spring 2024

MARKETING SOLUTIONS Largest Revenue Driver: Marketing Solutions Leading Network >73% of healthcare spend is decided by Doctors1 9:41 川兮 d $$ CH Children's Hospital of Philadelphia Sponsored suggested Pediatric Immunotherapy: What's Next for CAR-T Therapy Children's Hospital of Philadelp... Like Comment Share Subscription Pricing Model 1. Audience (e.g. specialty) 2. Number of audience members 3. Type and number of modules Health Systems 17:1 ROI LexisNexis 2 Pharma 3 11:1 ROI³ IQVIA 1. Center for Medicare & Medicaid Services, including categories of hospital care, physician & clinical services, retail prescription drugs, nursing care facilities & continuing care retirement communities, home health care, & durable medical equipment. 2. Our ROI studies are conducted using data from third party provider LexisNexis Risk Solutions for our health system customers. Median ROI as measured by third party claims data analysis of shared patient lift from new referring providers. As of September 2022. 3. Actual results vary based on therapy area, product price, product maturity, and the number of months over which the ROI was measured. As of September 2022. doximity Investor Presentation - February, 2024
View entire presentation